Cognitive Drug Research snapped up by United BioSource
This article was originally published in Scrip
Executive Summary
Improving the assessment of cognitive function in clinical trials is one of the reasons behind the acquisition of Cognitive Drug Research (CDR) by United BioSource. The financial terms of the acquisition were not disclosed.